MMJ Finalises C$2 Million Weed Me Inc. Investment

MMJ Finalises C$2 Million Weed Me Inc. Investment
MMJ Finalises C$2 Million Weed Me Inc. Investment
Perth, Dec 29, 2017 AEST (ABN Newswire) - MMJ PhytoTech Limited (ASX:MMJ) ("MMJ" or "the Company") is pleased to advise that it has finalised due diligence and signed the formal agreements to subscribe for C$2 million in secured convertible debentures ("Debentures") in Toronto-based Weed Me Inc. ("Weed Me") (see ASX announcement dated 12 December 2017).

- C$2 million funding advanced to late stage ACMPR applicant on improved terms

- Weed Me has recently obtained a certificate of readiness from Health Canada which is the final step before securing a Cultivation License

- Weed Me expected to secure Cultivation Licence within the next 120 days

- Weed Me is targeting entry into the estimated C$8 billion Canadian medical and recreational market in 2018 as a high quality, large-scale cannabis producer

Under the finalised agreement, MMJ has negotiated improved investment terms including a reduction in the pre-money valuation ("valuation") of Weed Me from C$10 million to C$9.2 million. The Debentures are convertible into shares and warrants in Weed Me based on the revised valuation.

The reduced valuation accounts for the exclusion of the real property that hosts Weed Me's proposed cannabis facility (the "Facility") located in Pickering, Ontario that has an estimated equity value of C$800,000 (corresponding to the reduced conversion price).

Importantly, the real property is still being put up as security for repayment of the Debentures. All other terms and conditions remain as outlined in the ASX announcement dated 12 December 2017.

Through this strategic investment, MMJ has now further strengthened its position in the Canadian cannabis sector, via its respective holdings in Harvest One Cannabis Inc. (CVE:HVST) (MMJ 59%) and near-term producer Weed Me.

Weed Me has also advised that it has received its certificate of readiness from Health Canada which is the final step in the process towards securing its Cultivation License. All that remains now is completion of the retrofit of Weed Me's Facility, with contractors having already commenced work on this prior to Christmas. As a result, Weed Me is confident of securing its cultivation licence under the ACMPR within next 120 days which will strategically coincide with the legalisation of the recreational cannabis market in July 2018.

About Weed Me Inc.

Established in 2016, Weed Me's short-term strategy is to become a LP with its Access to Cannabis for Medical Purposes Regulations ("ACMPR") A Cultivation License is expected to be granted to Weed Me within the next 120 days . Weed Me's long-term strategy is to provide the highest quality cannabis at the lowest cost per gram, utilizing unique genetics, full cultivation automation and industry leading grow space density.

About Harvest One Cannabis Inc

Harvest One Capital Inc. (CVE:HVT) (OTCMKTS:HRVOF) (FRA:2CN) is a global cannabis company focused on delivering high quality, innovative cannabis products and technology to regulated markets around the world. Our shareholders have significant exposure to the entire cannabis value chain through three business units, with Harvest One serving as the parent company over horticultural arm United Greeneries and medical arm Satipharm AG. Harvest One's businesses are all strategically located in favourable jurisdictions with supportive regulatory frameworks in place. United Greeneries has a Canadian ACMPR cultivation and sales license, making Harvest One a unique global company with the capacity to commercially cultivate and sell medicinal grade cannabis in a federally regulated environment.


About MMJ PhytoTech Ltd

Phytotech Medical ASX:PYL

In October 2017, MMJ PhytoTech Limited (ASX:MMJ) announced its strategy to become an incubator for strategic investments across regulated jurisdictions globally covering the entire cannabis value chain.

Following the successful listing of United Greeneries Holdings Ltd ("United Greeneries") and Satipharm AG ("Satipharm") on the TSX-V through Harvest One Cannabis Inc. (CVE:HVT), MMJ has focused on the identification of a number of independent strategic investment opportunities that have the potential to deliver significant value to the Company's shareholders.

MMJ is actively pursuing early stage opportunities with the ability to deliver significant future revenue and the opportunity to provide dramatic global synergistic value as regulatory frameworks in key international markets continue to evolve. MMJ is targeting the full range of emerging cannabis-related sectors including healthcare products, technology, infrastructure, logistics, processing, cultivation, equipment, R&D, hemp food products and retail.

MMJ currently holds an equity stake of 53,333,333 shares in Harvest One, 100% ownership of Israeli-based R&D division PhytoTech Therapeutics Limited ("PTL") and strategic holdings in e-Sense Lab Limited (ASX:ESE) and private Canadian-based company WeedMe Inc.



Andreas Gedeon
Managing Director
T: +1 (250) 713 6302

Related Companies

MMJ PhytoTech Ltd   
Harvest One Cannabis Inc

ABN Newswire This Page Viewed:  (Last 7 Days: 106) (Last 30 Days: 366) (Since Published: 4540) 

MMJ PhytoTech Ltd NEWS: RECENT VISITS (27969)

Research Report

Social Media